tiprankstipranks
Trending News
More News >
Anthera Pharmaceuticals, Inc. (ANTH)
:ANTH
US Market
Advertisement

Anthera Pharmaceuticals (ANTH) Income Statement

Compare
236 Followers

Anthera Pharmaceuticals Income Statement

Last quarter (Q1 2018), Anthera Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Anthera Pharmaceuticals's net income was $-4.43M. See Anthera Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 17
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -281.00K
Operating Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ 36.53M
Depreciation and Amortization
$ 228.49K$ 236.56K$ 206.30K$ 171.86K$ 281.00K
EBITDA
$ 0.00$ 0.00$ 0.00$ 0.00$ -26.59M
Operating Income
$ 0.00$ 0.00$ 0.00$ 0.00$ -36.43M
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ 9.56M
Pretax Income
$ 0.00$ 0.00$ 0.00$ 0.00$ -26.87M
Net Income
$ 0.00$ 0.00$ 0.00$ 0.00$ -16.93M
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ -1.65
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ -1.65
Weighted Average Shares Outstanding
22.17M 22.17M 22.17M 22.17M 10.28M
Weighted Average Shares Outstanding (Diluted)
22.17M 22.17M 22.17M 22.17M 10.28M
Currency in USD

Anthera Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis